This study aimed to use a low-molecular elastin-specific probe in MRI examinations and, thus, to obtain information on changes in the ECM during prostate cancer development for a better differentiation between tumor tissue and healthy tissue. This evidence concerns the gene ELN and prostate carcinoma.